Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-08-03
1985-05-07
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514913, A61K 31415
Patent
active
045158002
ABSTRACT:
A method is provided of treating glaucoma in a patient which comprises administering, preferably as eye drops, an effective amount of the compound ##STR1## which is preferably in the form of its hydrochloride. The compound is administered preferably in the form of a sterile pharmacologically acceptable solution which contains from 0.1 to 5, and more preferably 0.1 to 2.0, percent by weight of said compound. The patient preferably obtains the anti-glaucoma agent in the form of a kit which comprises the sterile pharmacologically acceptable solution and an eyedropper for dispensing said sterile pharmacologically acceptable solution to the affected eyes of a patient suffering from glaucoma.
REFERENCES:
patent: 2938038 (1960-05-01), Hirt
patent: 3236857 (1966-02-01), Zeik et al.
patent: 3468887 (1969-09-01), Stahle et al.
patent: 3622579 (1971-11-01), Stahle et al.
patent: 3636219 (1972-01-01), Culik et al.
patent: 3872121 (1975-03-01), Kummer et al.
patent: 3931216 (1976-01-01), Franymair
patent: 4125620 (1978-11-01), Stahle et al.
patent: 4166859 (1979-09-01), Stahle et al.
patent: 4213995 (1980-07-01), Stahle et al.
patent: 4250186 (1981-02-01), Stahle et al.
patent: 4262005 (1981-04-01), McCarthy et al.
patent: 4287201 (1981-09-01), Olson et al.
patent: 4293564 (1981-10-01), Stahle et al.
J. Pharmcol. Methods 6(2) 109-20 (1981)--Stahle et al.
J. Labelled Compd. Radiopharm 17(1) 35-41 (1980)--Rouot et al.
J. Med. Chem. 24 502-507 (1981)--Pieter et al.
Naunyn-Schmiedeberg's Arch Pharmacol 317(8)-12 (1881) DeJonge et al.
J. Anton. Pharmac. 1, 377-383 (1981) DeJonge et al.
Brit J. Pharmac. 71, 5-9 (1980) Roust et al.
Cr Acad. Sci. Pares 286 (1978)--Rouot et al.
Life Science 25, 769-774 (1979)--Rouot et al.
Invent. Ophthal 17(2)--149-158 Krieglotein et al."The Peripheral & Central Neural Action of Clonidine".
Chem. Abst. 92, 41,944(d) & 41946(f)--Stalhe et al. (1980).
"The Effect of Selective .alpha..sub.1 --and .alpha..sub.2 --Adrenocepter Stimulation on Intraocular Pressure in the Conscious Rabbit" by Innemee et al in Naunyn-Schmiedeberg's Arch Pharmacol (1981) 316, 294-298.
.intg.Electroencephalographic Studies on Clonidine and Para-Amino-clonidine, a Potent Peripherally Acting Imidazoline" by Depoortere et al. in Sleep (1980) pp. 297-800.
37 Pharmacological Studies on Para-Aminoclonidine" by Cavero et al. in British Journal of Pharmacology (1980) 69, 295P-296P.
"Synthese et reactivite de la p-aminochlonidine" by Rouot et al. in Bulletin de la Societe Chimique de France at (1979) 79 (9-10) pt2:502-528.
Cavero Icilio
Langer Salomon Z.
York, Jr. Billie M.
LandOfFree
Method of lowering intraocular pressure using phenylimino-imidaz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of lowering intraocular pressure using phenylimino-imidaz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of lowering intraocular pressure using phenylimino-imidaz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1799521